£15.00
PT-141, also identified as bremelanotide, is a cyclic heptapeptide melanocortin-receptor ligand, structurally a metabolite of Melanotan II in which the C-terminal amide group is replaced by a hydroxyl group. It is used in vitro in melanocortin-3 and melanocortin-4 receptor research, and is supplied lyophilised at 10 mg.
PT-141, also identified as bremelanotide, is a cyclic heptapeptide melanocortin-receptor ligand, structurally a metabolite of Melanotan II in which the C-terminal amide group is replaced by a hydroxyl group. It is used in vitro in melanocortin-3 and melanocortin-4 receptor research, and is supplied lyophilised at 10 mg.
| Format | Vial |
|---|---|
| Strength | 10mg |
